These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2092896)

  • 21. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
    Hooley E; McEwan PA; Emsley J
    J Thromb Haemost; 2007 Dec; 5(12):2461-6. PubMed ID: 17922805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
    Gallimore MJ; Harris SL; Jones DW; Winter M
    Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a microassay for human plasma prekallikrein.
    De La Cadena RA; Scott CF; Colman RW
    J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.
    Tankersley DL; Alving BM; Finlayson JS
    Blood; 1983 Aug; 62(2):448-56. PubMed ID: 6191802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin.
    Ratnoff OD
    J Lab Clin Med; 1980 Aug; 96(2):267-77. PubMed ID: 7400662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 29. [The so-called "contact" system of plasma: consequences of the activation of the Hageman factor].
    Damas J; Adam A
    Ann Biol Clin (Paris); 1988; 46(3):185-9. PubMed ID: 3044204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy.
    Egberg N; Bergström K
    Haemostasis; 1978; 7(2-3):85-91. PubMed ID: 149049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma.
    Friberger P; Gallimore MJ
    Adv Exp Med Biol; 1986; 198 Pt B():543-8. PubMed ID: 3643742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
    Ito R; Statland BE
    Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
    Briseid K; Lygren I; Johannesen S; Marthinsen K
    Scand J Clin Lab Invest; 2000 May; 60(3):237-45. PubMed ID: 10885496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Micromethod for determining prekallikrein in blood plasma using a chromogenic substrate].
    Kuznetsov VA
    Lab Delo; 1985; (7):400-2. PubMed ID: 2414517
    [No Abstract]   [Full Text] [Related]  

  • 36. Part of prekallikrein removed from human plasma together with IgG--immunoblot experiments and functional tests.
    Briseid K; Hoem NO; Johannesen S
    Scand J Clin Lab Invest; 1999 Feb; 59(1):55-63. PubMed ID: 10206098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XII assay with the chromogenic substrate chromozym PK.
    Dick W; Cullmann W; Müller N; Adler K
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):357-61. PubMed ID: 6168728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).
    Wang J; Matafonov A; Madkhali H; Mahdi F; Watson D; Schmaier AH; Gailani D; Shariat-Madar Z
    Curr Mol Med; 2014; 14(9):1173-85. PubMed ID: 25324000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of human plasma prekallikrein as a hemocompatibility test for biomaterials. II. Contact activation by EVAL and EVAL-SMA copolymers.
    Guerra GD; Barbani N; Lazzeri L; Lelli L; Palla M; Rizzo C
    J Biomater Sci Polym Ed; 1993; 4(6):643-52. PubMed ID: 8280677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of prekallikrein in the plasma of neonates].
    Simonianová E; Tomásová H; Rybák M; Zoban P; Mydililová A
    Cesk Pediatr; 1990 Oct; 45(10):596-9. PubMed ID: 2092896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.